This week on Pharm5:

  • Novavax protein-based COVID-19 vaccine
  • Pneumococcal Vaccine Decision Tree
  • Dupixent (dupilumab) for atopic dermatitis in kids 6 months to 5 years
  • Dostarlimab 100% effective in Phase II colorectal cancer trial
  • CHIP and Medicaid COVID-19 vaccine counseling codes

References:

  1. FDA Briefing Document Novavax COVID-19 Vaccine. FDA.gov. https://bit.ly/3tsOBxb. Published June 7, 2022. Accessed June 9, 2022.
  2. Haslett C, Carrington AE. ABC News. https://abcn.ws/3O2JtI3. Published June 7, 2022. Accessed June 9, 2022.
  3. Protecting adults against pneumococcal disease. National Foundation for Infectious Diseases. https://bit.ly/3aKYXlz. Published June 3, 2022. Accessed June 9, 2022.
  4. Brunk D. Dupilumab approved for eczema for children 6 months to 5 years. Medscape. https://wb.md/3QoWAFF. Published June 7, 2022. Accessed June 9, 2022.
  5. Cercek A, Lumish M, Sinopoli J, et al. PD-1 blockade in mismatch repair–deficient, locally advanced rectal cancer. New England Journal of Medicine. 2022. doi:10.1056/nejmoa2201445
  6. COVID-19 Stand-alone Vaccine Counseling-specific HCPCS Codes. Federal Policy Guidance | Medicaid.gov. https://bit.ly/3QffkY0. Published June 8, 2022. Accessed June 9, 2022.

See All 59 Episodes of "Pharm5"